KOSDAQ/068760 (KOSDAQ/068760)

KOSDAQ: KOSDAQ/068760 · KRW

₩37,100

+548.28 (+1.5%)· Recorded snapshot

Market cap	1.6T
Revenue (ttm)	274.7B
Net income (ttm)	26B
EPS (ttm)	₩583
Shares out	44.2M
P/E (trailing)	63.6x
Dividend	₩200 (0.54%)
Volume	33,759
Beta	0.90

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 274.7B
Net income (ttm): 26B
EPS (ttm): ₩583
P/E (trailing): 63.6x
Market cap: 1.6T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E63.6

P25 n/aP50 n/aP75 n/a

ROE8.9

P25 n/aP50 n/aP75 n/a

ROIC6.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All KOSDAQ/068760 indicators

Market & fundamental data

Available fields

236

Groups with data

Currency

KRW

Showing 236 of 236 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	KRW
Country	South Korea
Country code	KR
Employees	328
Exchange	KOSDAQ
Financial currency	KRW
Financial report date	2021-03-31
First seen	2026-05-10
Fiscal year end	December
Founded	1976
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	KR7068760008
Last refreshed	2026-10-28
Last stock split date	2025-12-29
Last stock split type	Forward
Market cap	KRW 1.6T
Price	KRW 37,100.00
Price currency	KRW
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	kosdaq/068760
Website	https://www.celltrionph.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	191.67x
Earnings yield	1.57%
FCF yield	-0.13%
Graham number	9467.65973
Graham upside	-74.48%
Industry forward P/E	13.69x
Industry P/E	18.5x
Lynch fair value	KRW 14,583.88
Lynch upside	-60.69%
P/(OCF - SBC) ratio	59.29x
P/B ratio	5.42x
P/E ratio	63.6x
P/OCF ratio	57.69x
P/S ratio	5.97x
Price / tangible book value	6.13x
Price/EBITDA ratio	38.33x
Sector forward P/E	24.78x
Sector P/E	49.55x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	10.51%
EBITDA margin	15.58%
Gross margin	29.43%
Operating margin	10.51%
Pretax margin	9.16%
Profit margin	9.47%
Profit per employee	KRW 79.3M
Profitable quarters	30
Profitable years	7
Revenue per employee	KRW 837.6M
ROA	3.41%
ROA (5Y)	0.86%
ROCE	7.92%
ROE	8.91%
ROE (5Y)	0.7%
ROIC	6.25%
ROIC (5Y)	1.56%
SBC / revenue	0.28%
Tax / revenue	-0.32%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	146.02%
EPS growth (Q)	226.23%
EPS growth (QoQ)	-32.38%
EPS growth 10Y	14.75%
EPS growth 3Y	75.76%
EPS growth quarters	8
EPS growth years	2
FCF growth (Q)	82.58%
FCF growth (QoQ)	29.5%
Gross profit growth	20.24%
Gross profit growth (Q)	47.31%
Gross profit growth 3Y	10.8%
Gross profit growth 5Y	10.88%
Net income growth	146.81%
Net income growth (Q)	228.36%
Net income growth (QoQ)	-32.34%
Net income growth 3Y	76.42%
Net income growth quarters	8
Net income growth years	2
OCF growth	-41.05%
OCF growth (Q)	-40.49%
OCF growth (QoQ)	-10.71%
OCF growth 10Y	25%
OCF growth 3Y	136.38%
Operating income growth	67.02%
Operating income growth (Q)	119.8%
Operating income growth 3Y	38.06%
Revenue growth	53.21%
Revenue growth (Q)	92.73%
Revenue growth (QoQ)	10.68%
Revenue growth 10Y	27.79%
Revenue growth 3Y	24.9%
Revenue growth 5Y	29.1%
Revenue growth quarters	11
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	KRW -30.6B
Depreciation and amortization	KRW 13.9B
EBIT	KRW 28.9B
EBITDA	KRW 42.8B
EPS	KRW 583.36
FCF per share	KRW -49.32
Financing cash flow	KRW 17B
Free cash flow	KRW -2.2B
Free cash flow minus SBC	KRW -2.9B
Gross profit	KRW 80.8B
Income taxes	KRW -874M
Investing cash flow	KRW -40.7B
Net borrowing	KRW 23.7B
Net cash flow	KRW 4.8B
Net income	KRW 26B
Operating cash flow minus SBC	KRW 27.7B
Operating income	KRW 28.9B
Revenue	KRW 274.7B
Stock-based compensation	KRW 767.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	11.76
Book value per share	KRW 6,829.20
Debt / EBITDA	4.48
Debt / equity	0.63
Goodwill	KRW 32.9B
Interest coverage	6.22
Long-term assets	KRW 315.7B
Long-term liabilities	KRW 61.9B
Net cash (debt)	KRW -157.1B
Net cash / market cap	-9.58%
Net debt / EBITDA	3.67
Net debt / equity	0.52
Piotroski F-Score	6
Property, plant and equipment	KRW 247.1B
Shareholders' equity	KRW 302.8B
Tangible book value	KRW 267.7B
Tangible book value per share	KRW 6,038.31
Total assets	KRW 572.9B
Total cash	KRW 34.6B
Total debt	KRW 191.8B
Total liabilities	KRW 270.1B
WACC	8.42%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.52
Current assets	KRW 257.2B
Current liabilities	KRW 208.3B
Current ratio	1.23
Inventory turnover	4.2
Net working capital	KRW 150B
Quick ratio	0.92
Working capital	KRW 48.9B
Working capital turnover	6.65

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.23%
Dividend growth	0%
Dividend growth years	1
Dividend payment date	2026-04-17
Dividend payment years	1
Dividend per share	KRW 200.00
Dividend yield	0.54%
Ex-dividend date	2025-12-29
Last dividend	KRW 200.00
Payout ratio	34.28%
Shareholder yield	0.31%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	130.54%
10Y return CAGR	8.75%
10Y total return	131.29%
150-day SMA	KRW 45,412.67
15Y price change	141.79%
15Y return CAGR	6.09%
15Y total return	142.57%
1D price change	1.5%
1M price change	-4.99%
1M total return	-4.99%
1W price change	-5.72%
1W total return	-5.72%
1Y price change	-39.16%
1Y return CAGR	-38.98%
1Y total return	-38.96%
20-day SMA	KRW 38,352.50
200-day SMA	KRW 50,740.00
20Y price change	578.47%
20Y return CAGR	10.15%
20Y total return	590.91%
3M price change	-9.18%
3M total return	-9.18%
3Y price change	-34.81%
3Y return CAGR	-13.2%
3Y total return	-34.6%
50-day SMA	KRW 39,878.00
50-day SMA vs 200-day SMA	50under200
52-week high	KRW 78,300.00
52-week high date	2026-02-24
52-week low	KRW 35,600.00
52-week low date	2026-10-15
5Y price change	-62.95%
5Y return CAGR	-17.96%
5Y total return	-62.83%
6M price change	-35.92%
6M total return	-35.92%
All-time high	KRW 221,035.48
All-time high date	2020-12-28
All-time low	KRW 2,770.55
All-time low date	2008-12-08
Average true range (ATR)	KRW 1,372.65
Average volume	69K
Beta (1Y)	0.66
Beta (2Y)	0.52
Beta (5Y)	0.9
Change from 52-week high	-52.62%
Change from 52-week low	4.21%
Change from all-time high	-83.22%
Change from all-time low	1,239.09%
Change from open	1.09%
Day's gap	0.41%
Dollar volume	KRW 1.3B
High price	KRW 37,600.00
Low price	KRW 36,700.00
Monthly RSI	36.89
Open price	KRW 36,700.00
Position in 52-week range	44.44%
Previous close	KRW 36,550.00
Price vs 150-day SMA	-18.3%
Price vs 20-day SMA	-3.27%
Price vs 200-day SMA	-26.88%
Price vs 50-day SMA	-6.97%
Relative volume	0.49
RSI	41.91
Sharpe ratio	-0.74
Sharpe ratio (3Y)	-0.25
Sharpe ratio (5Y)	-0.41
Sortino ratio	-0.94
Sortino ratio (3Y)	-0.25
Sortino ratio (5Y)	-0.51
Volume	33.8K
Weekly RSI	31.55
YTD price change	-36.03%
YTD total return	-36.03%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	19.7M
Shares change (QoQ)	-0.19%
Shares held by insiders	0.16%
Shares held by institutions	3.38%
Shares outstanding	44.2M

Deeper analysis on KOSDAQ/068760

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this KOSDAQ/068760 report

Is a complete KOSDAQ/068760 research report available?

No complete published report is available for kosdaq/068760 (KOSDAQ/068760) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

KOSDAQ/068760 (KOSDAQ/068760)

Price

Financial snapshot

Fair-value bridge

Latest news · KOSDAQ/068760

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All KOSDAQ/068760 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on KOSDAQ/068760

Frequently asked questions